Completed NCT00132678
This study is completed in the United States, in Austria, in India, .... It is testing safety and Efficacy of Injectable Risperidone for Bipolarity.
Multiple locations, including Little Rock Bipolarity Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries United States, Austria, India, ...
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Bipolarity Completed NCT00477672
This study is completed in the United States, in France, in the United Kingdom, .... It is testing safety and Efficacy of Pimavanserin for Schizophrenia.
Multiple locations, including Gilbert Schizophrenia Drug Over 40 Years
Countries United States, France, United Kingdom, ...
Sponsor ACADIA Pharmaceuticals Inc.
Condition Schizophrenia Completed NCT02035553
This study is completed in the United Kingdom. It is testing safety and Efficacy of Pimavanserin for Schizophrenia.
In London Schizophrenia Drug Over 50 Years
Countries United Kingdom
Sponsor ACADIA Pharmaceuticals Inc.
Condition Schizophrenia Completed NCT06068465
This study is completed in China. It is testing safety and Efficacy of Pimavanserin for Schizophrenia.
Multiple locations, including Hefei Schizophrenia Drug Over 40 Years
Countries China
Sponsor Tasly Pharmaceutical Group Co., Ltd
Condition Schizophrenia Completed NCT04479852
This study is completed in the United States. It is testing Safety and Efficacy of SP-624 for depression.
Multiple locations, including Phoenix Depression Drug From 18 Years to 65 Years
Countries United States
Sponsor Sirtsei Pharmaceuticals, Inc.
Condition Depression Completed NCT00650611
This study is completed in the United States. It is testing ziprasidone for Schizophrenia.
Multiple locations, including San Diego Schizophrenia, Bipolarity Drug From 10 Years to 17 Years
Countries United States
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Schizophrenia, Bipolarity Completed NCT00550238
This study is completed in the United States, in France, in Canada, .... It is testing pimavanserin for Schizophrenia.
Multiple locations, including Gilbert Schizophrenia Drug Over 40 Years
Countries United States, France, Canada, ...
Sponsor ACADIA Pharmaceuticals Inc.
Condition Schizophrenia Completed NCT04510298
This study is completed in the United States. It is testing Safety, PK, and Exploratory Efficacy of SP-624 for schizophrenia.
Multiple locations, including Garden Grove Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor Sirtsei Pharmaceuticals, Inc.
Condition Schizophrenia Completed NCT02019329
This study is completed in the United States. It is testing Safety, Tolerability and Pharmacokientics of RO5545965 for schizophrenia.
In Glendale Schizophrenia Other From 18 Years to 60 Years
Countries United States
Sponsor Hoffmann-La Roche
Condition Schizophrenia Completed NCT01429740
This study is completed in the United States. It is testing Single Doses Of PF-05180999 for Schizophrenia.
In New Haven Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor Pfizer
Condition Schizophrenia Completed NCT03582137
This study is completed in the United States. It is testing tolerability and Efficacy of Cannabidiol on Motor Symptoms for Schizophrenia.
In Aurora Schizophrenia Drug From 40 Years to 85 Years
Countries United States
Sponsor University of Colorado, Denver
Condition Schizophrenia Completed NCT02818777
This study is completed in the United States. It is testing tolerability and Efficacy of Cannabidiol on Tremor for Schizophrenia.
In Aurora Schizophrenia Drug From 40 Years to 80 Years
Countries United States
Sponsor University of Colorado, Denver
Condition Schizophrenia